Investigational combination of first-in-class bispecifics TALVEY® and TECVAYLI® shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease ...Middle East

Results from the Phase 2 RedirecTT-1 study demonstrate deep responses with 78.9 percent overall response rate through dual targeting of GPRC5D and BCMA Data signal potential of novel, off-the-shelf approach in patients with extramedullary disease who face significant unmet needs MILAN,...

Read More Details
Finally We wish PressBee provided you with enough information of ( Investigational combination of first-in-class bispecifics TALVEY® and TECVAYLI® shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease )

Also on site :

• Russia’s strong ties with both Israel and Iran could help it emerge as a power broker
• NYT ‘Connections’ Hints and Answers Today, Sunday, June 15
• Early Edition Soap Opera Comings & Goings Week of June 16, 2025